Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GE HealthCare Technologies (GEHC) Gains from Investment Securities (2022 - 2025)

GE HealthCare Technologies (GEHC) has disclosed Gains from Investment Securities for 4 consecutive years, with $28.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gains from Investment Securities fell 93.02% year-over-year to $28.0 million, compared with a TTM value of $69.0 million through Dec 2025, down 85.95%, and an annual FY2025 reading of $69.0 million, down 85.95% over the prior year.
  • Gains from Investment Securities was $28.0 million for Q4 2025 at GE HealthCare Technologies, up from -$229.0 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $401.0 million in Q4 2024 and bottomed at -$229.0 million in Q3 2025.
  • Average Gains from Investment Securities over 4 years is $64.6 million, with a median of $88.5 million recorded in 2024.
  • The sharpest move saw Gains from Investment Securities skyrocketed 417.81% in 2023, then plummeted 152.12% in 2024.
  • Year by year, Gains from Investment Securities stood at -$73.0 million in 2022, then skyrocketed by 235.62% to $99.0 million in 2023, then surged by 305.05% to $401.0 million in 2024, then crashed by 93.02% to $28.0 million in 2025.
  • Business Quant data shows Gains from Investment Securities for GEHC at $28.0 million in Q4 2025, -$229.0 million in Q3 2025, and $179.0 million in Q2 2025.